Page last updated: 2024-08-22

tranylcypromine and Carcinoma, Squamous Cell of Head and Neck

tranylcypromine has been researched along with Carcinoma, Squamous Cell of Head and Neck in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cheng, J; Diao, P; Jiang, H; Wang, D; Wang, Y; Zhang, W1

Other Studies

1 other study(ies) available for tranylcypromine and Carcinoma, Squamous Cell of Head and Neck

ArticleYear
Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1.
    British journal of cancer, 2020, Volume: 122, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzazepines; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Enzyme Inhibitors; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Mice; Mice, Inbred C57BL; Mice, Nude; Pyrimidines; Squamous Cell Carcinoma of Head and Neck; Tranylcypromine; Xenograft Model Antitumor Assays

2020